Transmembrane AMPA Receptor Regulatory Protein (TARP) Dysregulation in Anterior Cingulate Cortex in Schizophrenia.

Drummond JB, Tucholski J, Haroutunian V, Meador-Woodruff JH: Transmembrane AMPA Receptor Regulatory Protein (TARP) Dysregulation in Anterior Cingulate Cortex in Schizophrenia.  Schizophrenia Research. In press.

An fMRI investigation of temporal discounting in patients with schizophrenia.

Kathy B. Avsar, James E. Cox, Rosalyn E. Weller, Meredith Reid, David White, Adrienne C. Lahti. An fMRI investigation of temporal discounting in patients with schizophrenia. In Press, Brain and Behavior.

Antipsychotic drugs altered functional connectivity between medial frontal cortex, hippocampus, and ventral striatum.

  • Mark S Bolding, David M White, Jennifer A Hadley, Martin Weiler, Henry H Holcomb, and Adrienne C Lahti. Antipsychotic drugs altered functional connectivity between medial frontal cortex, hippocampus, and ventral striatum. Frontiers in Psychiatry, 3: 105, 2012.

Identifying suicidal behavior among adolescents using administrative claims data.

Callahan, S.T., Fuchs D.C., Shelton R.C., Balmer L.S., Dudley J.A., Gideon P.S., DeRanieri M.M., Stratton S.M, Williams C.L., Ray W.A., Cooper W.O. Identifying suicidal behavior among adolescents using administrative claims data. Pharmacoepidemiology and Drug Safety 22:769-775, 2013.

Read more...

Abnormal N-linked Glycosylation of Cortical AMPA Receptor Subunits in Schizophrenia.

  • Tucholski J, Simmons MS, Pinner AL, Haroutunian V, McCullumsmith RE, and Meador-Woodruff JH:  Abnormal N-linked Glycosylation of Cortical AMPA Receptor Subunits in Schizophrenia.  Schizophrenia Research. In press

Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development.

Nierenberg A.A., Kansky C., Brennan B.P., Shelton R.C., Perlis R., Iosifescu D.V. Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development. Australian and New Zealand Journal of Psychiatry 47:26-42, 2012

A 12-week, randomized, double-blind, placebo-controlled, parallel-sequential trial of ziprasidone as monotherapy for major depressive disorder.

Papakostas G.I., Vitolo O.V., Ishak W.W., Rapaport M.H., Zajecka J.M., Kinrys G., Mishoulon D., Lipkin S.H., Abrams J., Ward S.G., Meisner A., Schoenfeld D.A., Shelton R.C., Winokur A., Okasha M.S., Bari M.A., Fava M. A 12-week, randomized, double-blind, placebo-controlled, parallel-sequential trial of ziprasidone as monotherapy for major depressive disorder. J. Clin Psychiatry 73:1541–1547, 2012

Lithium controls Central Nervous System autoimmunity through regulation of IFNγ signaling

Rowse, A., L., Naves, R., Cashman, K., S., McGuire, D.J., Mbana, T., Raman, C., and De Sarno, P*., 2012. Lithium controls Central Nervous System autoimmunity through regulation of IFNγ signaling. PLoS One, 7(12): e52658. Epub 2012 Dec 28.

Abnormal Expression of Glutamate Transporters in Temporal Lobe Areas in Elderly Patients With Schizophrenia

Shan D, Lucas EK,Drummond JB, Haroutunian V, Meador-Woodruff JH, McCullumsmith RE:  Abnormal Expression of Glutamate Transporters in Temporal Lobe Areas in Elderly Patients With Schizophrenia.  Schizophrenia Research. In press.

Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons

Jiang Z, Rompala G, Zhang S, Cowell RM, Nakazawa K. Social isolation exacerbates schizophrenia-like phenotypes via oxidative stress in cortical interneurons. Biological PsychiatryIn press